MedPath

A retrospective study to explore the biomarkers in lung cancer immunotherapy, 2nd stage -irAE prediction

Not Applicable
Conditions
ung cancer
Registration Number
JPRN-UMIN000051528
Lead Sponsor
ational Cancer Center Hospital East
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
350
Inclusion Criteria

Not provided

Exclusion Criteria

Not applicable

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HLA alleles
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath